Literature DB >> 15863587

Follicle stimulating hormone-secreting pituitary microadenoma with fluctuating levels of ovarian hyperstimulation.

Tetsuo Maruyama1, Hirotaka Masuda, Hiroshi Uchida, Takashi Nagashima, Yasunori Yoshimura.   

Abstract

BACKGROUND: Enlarged multicystic ovaries and an elevated estradiol (E2) concentration have been reported as characteristics of follicle stimulating hormone (FSH)-secreting adenomas in reproductive-aged women. The natural course of the hormone in relationship to the microadenoma and ovarian findings, however, remains largely unknown. CASE: A 40-year-old woman with enlarged multicystic ovaries was nonsurgically diagnosed with an FSH-producing pituitary microadenoma. During her subsequent 12-month follow-up, the serum concentration of E2, but not FSH, and the size of the multicystic ovaries fluctuated dramatically. Both the E2 level and ovarian size were transiently normalized.
CONCLUSION: Because of disease-related fluctuations, a reproductive-aged woman with an FSH-producing adenoma did not always present with laboratory values characteristic of ovarian hyperstimulation. This finding points out a possible pitfall in diagnosis and clinical management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15863587     DOI: 10.1097/01.AOG.0000141554.50747.16

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  4 in total

1.  Ectopic expression of tethered human follicle-stimulating hormone (hFSH) gene in transgenic mice.

Authors:  Myoung Ok Kim; Sung Hyun Kim; Sang Ryeul Lee; Mi Jung Shin; Kwan Sik Min; Dong Beom Lee; Sung Won Lee; Kil Soo Kim; Sun Jung Kim; Zae Young Ryoo
Journal:  Transgenic Res       Date:  2006-11-11       Impact factor: 2.788

2.  Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma.

Authors:  Odelia Cooper; Jordan L Geller; Shlomo Melmed
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-02-12

3.  Molecular analysis of a mutated FSH receptor detected in a patient with spontaneous ovarian hyperstimulation syndrome.

Authors:  Sayaka Uchida; Hiroshi Uchida; Tetsuo Maruyama; Takashi Kajitani; Hideyuki Oda; Kaoru Miyazaki; Maki Kagami; Yasunori Yoshimura
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

Review 4.  Updating the Landscape for Functioning Gonadotroph Tumors.

Authors:  Georgia Ntali; Cristina Capatina
Journal:  Medicina (Kaunas)       Date:  2022-08-08       Impact factor: 2.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.